Antitumor agent
US8476260B2 · kind B2 · utility
41Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 26, 2008 |
| Grant date | Jul 2, 2013 |
| Priority date | — |
| Expiry date | Sep 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel antitumor agent containing a compound that inhibits binding between acetylated histone and a bromodomain-containing protein, preferably a thienotriazolodiazepine compound represented by the following formula (I)wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof or a hydrate or solvate as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.